Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

FairJourney Biologics ‘future-proofs’ therapeutic antibody

Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like molecules, has been selected by FairJourney Biologics, a leading contract research organization (CRO), to support the company’s growth as it incorporates increasingly large Sanger data sets and next-generation sequencing (NGS) into its discovery programs.

Geneious Biologics is Biomatters’ cloud-based enterprise software for analysis of antibodies and related constructs using DNA sequence data. The software applies intuitive visualization tools and advanced analytics to help specialist biologic drug development companies accelerate identification of therapeutic candidates.

Geneious Biologics was selected by FairJourney Biologics for its ability to automate analysis and quality control (QC) with accurate identification of relevant regions, sequence liabilities, errors and frame shifts.

“We are processing increasingly larger sets of antibody sequences,” said Daniela Teixeira, COO, FairJourney Biologics. “Geneious Biologics allows us to drill into huge antibody sequence sets and quickly identify where errors lie and inspect bad clones. This will ensure we return the most effective, stable therapeutic antibody candidates to our clients, faster.”

“We are excited that FairJourney Biologics is preparing for growth and future-proofing its discovery efforts with Geneious Biologics. There is a step change happening in the therapeutic antibody discovery industry as leading research enterprises like FairJourney Biologics leverage the power of high throughput antibody sequencing,” said Jannick Bendtsen, Vice President of Technology Services, Geneious Biologics.

“Our focus is building the world’s most robust and functional sequence analysis platform to help our customers deliver quicker, more accurate results and identify therapeutic antibody candidates faster.”

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Forest And Bird: Misinformation Circulating On Biodiversity Policy

Forest & Bird is concerned at misinformation circulating regarding a policy statement aimed at protecting New Zealand’s unique biodiversity. The National Policy Statement for Indigenous Biodiversity is being consulted on by the ... More>>

ALSO:

NIWA: Scientists Say Methane Emitted By Humans ‘vastly Underestimated’

NIWA researchers have helped unlock information trapped in ancient air samples from Greenland and Antarctica that shows the amount of methane humans are emitting into the atmosphere from fossil fuels has been vastly underestimated... More>>

ALSO:

SMC Expert Reaction: Record Dry Spells And Effects On Forests

With no rain forecast before Sunday, Auckland is about to break a record for the city's longest dry spell. Niwa says Auckland is likely to hit 40 consecutive days without rain this weekend . The upper North Island is seeing severe meterological ... More>>

ALSO:



Reserve Bank: Official Cash Rate Remains At 1.0 Percent

The Monetary Policy Committee has decided to keep the Official Cash Rate (OCR) at 1.0 percent. Employment is at or slightly above its maximum sustainable level while consumer price inflation is close to the 2 percent mid-point of our target range. ... More>>

ALSO:

Science Media Centre: Novel Coronavirus Detected In China – Expert Reaction

The virus was detected after more than 40 people were hospitalised with pneumonia in Wuhan City, China and the outbreak traced to a large animal and seafood market. The Centers for Disease Control and Prevention reports that person-to-person transmission ... More>>

ALSO:

NZ First: Launch Of Parliament Petition To Remove Aluminium Dross

This afternoon to a crowd of over 100 people in Mataura -- Mark Patterson, New Zealand First List MP based in Clutha-Southland launched a parliamentary petition regarding the aluminium dross issue in Mataura, Southland. The petition asks that the House ... More>>

ALSO: